WHO WE WORK WITH
Commercial strategy and execution for life science companies, investors and emerging technologies.
HOW CLIENTS ENGAGE UBC
Engagements can begin with a focused question and expand as the commercial path becomes clear.
1. Assess the Opportunity
Commercial assessment, market research, competitive analysis and Voice of Customer.
↓
2. Define the Strategy
Positioning, messaging, go-to-market strategy, pricing and operating priorities.
↓
3. Build the Commercial Engine
Commercial plans, sales tools, partnerships, pipeline development and organizational design.
↓
4. Execute & Scale
Business development, sales execution and fractional or interim leadership.
↓
5. Support the Next Strategic Move
Fundraising, diligence, transaction support and commercial transition.
Focused project. Fractional leadership. Integrated team.
GROWTH & EXIT CASE STUDY — TRINEAN
THE OPPORTUNITY
Trinean needed to move beyond a flat distributor-led U.S. business and create a scalable growth engine.
U.S. revenue had remained near $500K annually for roughly two years. UBC was engaged to sharpen the market strategy, expand direct commercial coverage and help position the company for its next stage of growth.
UBC Response & Outcomes
1. Rebuild the Commercial Model
UBC helped shift the U.S. business away from dependence on a regional distributor and built broader direct market coverage with experienced commercial resources.
2. Scale the Infrastructure
The commercial organization expanded to include regional representation, sub-dealers, service capability and sales-office support as customer traction accelerated.
3. Growth to Strategic Exit
Within roughly 18 months, U.S. revenue reached a run rate of more than $5M annually. Trinean was subsequently acquired by Unchained Labs.
OPERATOR & TRANSACTION CASE STUDY — ORFLO
THE OPPORTUNITY
UBC saw an opportunity to apply its commercialization model as an owner and operator—not only as an advisor.
UBC acquired ORFLO Technologies from Gemini BioProducts in 2022 and took an active role in commercial strategy, market development, organizational focus and operating execution.
UBC as Owner & Operator
1. Acquire & Refocus
UBC moved from consulting into direct ownership, aligning commercial priorities, management resources and market-development activity around ORFLO’s core cell-analysis platform.
2. Build for the Next Stage
UBC expanded the operating platform, relocated the company headquarters to the San Diego area and positioned the business to participate in a broader cell-analysis strategy.
3. Complete the Transaction
ORFLO was sold to Precision Cell Systems in 2025 and combined with S2 Genomics, completing the next phase of UBC’s ownership and commercialization strategy.
PRE-COMMERCIAL LAUNCH CASE STUDY — BIAMETRICS
THE OPPORTUNITY
A pre-commercial technology company needed capital, market validation and a practical path to launch.
UBC was engaged to help secure funding for product development, create customer-backed proof points, launch initial products and establish commercial channels without building a full internal organization.
UBC Response & Outcomes
1. Fund Development
UBC supported the financing strategy and commercial story that helped the company secure more than $2M to advance product development.
2. Validate & Launch
Four customer-funded laboratory projects created market validation while UBC helped prepare and launch the company’s first commercial offerings.
3. Build Early Traction
Following launch of bPortable, the commercial pipeline grew to more than $200K in the first month, providing early evidence of market demand.
UBC Across the Company Lifecycle
UBC engagements are modular. We can enter at a focused decision point, add the capabilities required for the next stage, or remain embedded through execution, financing and transaction.
1. Assess & Validate
Market assessment, competitive analysis, Voice of Customer, diligence and opportunity prioritization.
Biodesy • BioFluidica • Quanterix • Singulex
2. Position & Prepare to Launch
Positioning, messaging, pricing, commercial planning and early customer validation.
Biametrics • Biodesy • BioFluidica • Quanterix
3. Enter New Markets
U.S. market entry, geographic expansion, application expansion and channel development.
Trinean • ArrayJet • Lifeonics • RedShift Bio
4. Execute & Accelerate Growth
Embedded commercial leadership, business development, sales execution, pipeline development and team augmentation.
Trinean • ArrayJet • ORFLO • Nuclera
5. Finance & Build Enterprise Value
Investor positioning, commercial de-risking, financing preparation and capital-process support.
Biametrics • Trinean • ORFLO • FreMon Scientific
6. Transform, Operate & Transact
Commercial restructuring, operating involvement, M&A preparation, ownership and transaction support.
Trinean • ArrayJet • ORFLO • Precision Cell Systems
Illustrative, not comprehensive.
United BioChannels
Copyright 2026